1.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

2.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

3.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

4.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

5.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

6.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

7.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

8.

Single alteration leading to colistin resistance (no other mutations in PmrAB and PhoPQ detected).

1.

Origin and characteristics of clonally related isolates.

2.

Origin and characteristics of clonally related isolates.

3.

Origin and characteristics of clonally related isolates.

4.

Origin and characteristics of clonally related isolates.

5.

Origin and characteristics of clonally related isolates.

6.

Origin and characteristics of clonally related isolates.

7.

Origin and characteristics of clonally related isolates.

8.

Origin and characteristics of clonally related isolates.

1.

Fig 1 -

2.

Fig 1 -

3.

Fig 1 -

4.

Fig 1 -

5.

Fig 1 -

6.

Fig 1 -

7.

Fig 1 -

8.

Fig 1 -

1.

Sankey diagram of the origin and genetic context of mcr -genes.

2.

Sankey diagram of the origin and genetic context of mcr -genes.

3.

Sankey diagram of the origin and genetic context of mcr -genes.

4.

Sankey diagram of the origin and genetic context of mcr -genes.

5.

Sankey diagram of the origin and genetic context of mcr -genes.

6.

Sankey diagram of the origin and genetic context of mcr -genes.

7.

Sankey diagram of the origin and genetic context of mcr -genes.

8.

Sankey diagram of the origin and genetic context of mcr -genes.

1.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

2.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

3.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

4.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

5.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

6.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

7.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

8.

Phenotypic antibiotic resistance of colistin-resistant Enterobacterales.

1.

Fig 4 -

2.

Fig 4 -

3.

Fig 4 -

4.

Fig 4 -

5.

Fig 4 -

6.

Fig 4 -

7.

Fig 4 -

8.

Fig 4 -

1.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

2.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

3.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

4.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

5.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

6.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

7.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

8.

Insights into the resistance to critically important antibiotics and the number of virulence classes present in colistin-resistant isolates from different One Health sectors.

1.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

2.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

3.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

4.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

5.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

6.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

7.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

8.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

9.

Comparison of colistin resistance between Belgium and the Netherlands by measurement and by sector.

1.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

2.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

3.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

4.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

5.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

6.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

7.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

8.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).

9.

Association of colistin resistance with prior colistin use in pig farms in Belgium (n = 14) and the Netherlands (n = 15).